CLINICAL_TRIALS
trial_result
· 2012-07-23
Clinical Trial Update: A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02) [Phase 1]
Summary
A Phase 1 pharmacokinetics study of MK-0941 in participants with renal impairment was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED | Results posted: 2012-07-23